FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

T Mikayama

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Enzyme-Linked Immunosorbent Assay

Physiology

Transfection

Co-author Network

Publications

TOP 3
Nakayuki Honma; H Koseki; T Akasaka; T Nakayama; M Taniguchi; Isao Serizawa; Hiromichi Akahori; M Osawa; T Mikayama
Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia.
Takafumi Tomura; Hiroshi Watarai; Nakayuki Honma; M Sato; A Iwamatsu; Y Kato; Ryota Kuroki; T Nakano; T Mikayama; KIMISHIGE ISHIZAKA
Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants.
Katsuji Sugie; T Nakano; Takafumi Tomura; K Takakura; T Mikayama; KIMISHIGE ISHIZAKA
High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of T Mikayama (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Nakayuki Honma; H Koseki; T Akasaka; T Nakayama; M Taniguchi; Isao Serizawa; Hiromichi Akahori; M Osawa; T Mikayama
Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia.
Immunology 2000;100(1):84-90.
1999: Takafumi Tomura; Hiroshi Watarai; Nakayuki Honma; M Sato; A Iwamatsu; Y Kato; Ryota Kuroki; T Nakano; T Mikayama; KIMISHIGE ISHIZAKA
Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):195-202.
1997: Katsuji Sugie; T Nakano; Takafumi Tomura; K Takakura; T Mikayama; KIMISHIGE ISHIZAKA
High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(10):5278-83.
1997: T Nakano; Hiroshi Watarai; Yun-Cai Liu; Y Oyama; T Mikayama; KIMISHIGE ISHIZAKA
Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(1):202-7.
1996: Y Kato; T Muto; Takafumi Tomura; H Tsumura; Hiroshi Watarai; T Mikayama; KIMISHIGE ISHIZAKA; Ryota Kuroki
The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(7):3007-10.
1996: KIMISHIGE ISHIZAKA; T Nakano; Y Ishii; Yun-Cai Liu; T Mikayama; A Mori
Controversial issues and possible answers on the antigen-specific regulation of the IgE antibody response.
Advances in experimental medicine and biology 1996;409():317-25.
1996: N Honma; Y Matsuda; Y Ishii; M Sato; Takafumi Tomura; N Yuyama; T Mikayama
Cloning and mapping of the mouse glycosylation-inhibiting factor gene and four related genes.
Mammalian genome : official journal of the International Mammalian Genome Society 1996;7(1):59-61.
1995: T Onda; D LaFace; Gottfried Baier; Thomas Brunner; N Honma; T Mikayama; A Altman; Douglas R Green
A phage display system for detection of T cell receptor-antigen interactions.
Molecular immunology 1995;32(17-18):1387-97.
1995: T Nakano; Yun-Cai Liu; T Mikayama; Hiroshi Watarai; M Taniguchi; KIMISHIGE ISHIZAKA
Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(20):9196-200.
1994: H Inoue; T Kadoya; K Kabaya; K Tachibana; N Nishi; M Sato; M Ohsawa; T Mikayama; K J Mori
A highly enhanced thrombopoietic activity by monomethoxy polyethylene glycol-modified recombinant human interleukin-6.
The Journal of laboratory and clinical medicine 1994;124(4):529-36.
1994: H Gomi; Yutaka Tagaya; T Nakano; T Mikayama; KIMISHIGE ISHIZAKA
Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2824-8.
1993: T Mikayama; T Nakano; H Gomi; Y Nakagawa; Yun-Cai Liu; M Sato; A Iwamatsu; Y Ishii; W Y Weiser; KIMISHIGE ISHIZAKA
Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(21):10056-60.
1993: Yun-Cai Liu; M Kawagishi; T Mikayama; Y Inagaki; T Takeuchi; H Ohashi
Processing of a fusion protein by endoprotease in COS-1 cells for secretion of mature peptide by using a chimeric expression vector.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(19):8957-61.
1992: Cornelia Zeidler; L Kanz; F Hurkuck; K L Rittmann; Ingeborg Wildfang; T Kadoya; T Mikayama; L Souza; Karl Welte
In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates.
Blood 1992;80(11):2740-5.
1992: Hiroshi Miyazaki; H Inoue; M Yanagida; K Horie; T Mikayama; H Ohashi; M Nishikawa; T Suzuki; T Sudo
Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa.
Experimental hematology 1992;20(7):855-61.